2026-04-21 04:59:16
Latest Post
MCX receives SEBI approval to incorporate a new Coal Exchange
RailTel Corporation of India Ltd receives LoA worth Rs. 86.36 crores
Nelco Limited Announces FY26 Results: Operations Remain Steady Amid Exceptional Adjustments
UGRO Capital Announces FY26 Results: Total Income Surpasses ₹1,840 Crore
Indosolar Limited Reports Exponential Profit Growth; FY26 Revenue Doubles to ₹679 Crore
Stock Report
Sun Pharmaceutical Q4 profit after tax at Rs.155.67 crores
Posted On : 2007-05-18 03:08:44( TIMEZONE : IST )
Sun Pharmaceutical Industries Ltd has announced the financial results for the quarter & year ended March 31, 2007. The Unaudited results for the Quarter ended March 31, 2007 are as follows: The Company has posted a profit after tax of Rs 1556.70 million for the quarter ended March 31, 2007 as compared to Rs 1158.90 million for the quarter ended March 31, 2006. Total Income (net of excise) has increased from Rs 4545.30 million for the quarter ended March 31, 2006 to Rs 6337.40 million for the quarter ended March 31, 2007.
The Audited results for the Year ended March 31, 2007 are as follows: The Company has posted a profit after tax of Rs 6289.30 million for the year ended March 31, 2007 as compared to Rs 4612.90 million for the year ended March 31, 2006. Total Income (net of excise) has increased from Rs 18051.20 million for the year ended March 31, 2006 to Rs 24040.50 million for the year ended March 31, 2007.
The Unaudited consolidated results for the Quarter ended March 31, 2007 are as follows: The Group has posted a net profit of Rs 2120.80 million for the quarter ended March 31, 2007 as compared to Rs 1429.20 million for the quarter ended March 31, 2006. Total Income (net of excise) has increased from Rs 4821.20 million for the quarter ended March 31, 2006 to Rs 6383.70 million for the quarter ended March 31, 2007.
The Unaudited consolidated results for the Year ended March 31, 2007 are as follows: The Group has posted a net profit of Rs 7740.80 million for the year ended March 31, 2007 as compared to Rs 5732.50 million for the year ended March 31, 2006. Total Income (net of excise) has increased from Rs 18033.50 million for the year ended March 31, 2006 to Rs 23573.40 million for the year ended March 31, 2007.
The figures for the consolidated results for the year ended are Audited.
The Board of Directors had recommended that the interim dividend at the rate of 135% (Rs 6.75 per share) on the equity share capital and at the rate of 6% (Rs 0.06 per share) on the outstanding redeemable preference shares declared at its meeting held on March 10, 2007 and paid, be treated as final dividend for the financial year 2006-07.
